Trial Information
Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer
Inclusion Criteria:
1. FEMALE SUBJECT BETWEEN 18 AND 75 YEARS OF AGE.
2. ABILITY TO PROVIDE INFORMED CONSENT
Exclusion Criteria:
1. SUBJECT WITH KNOWN PREGNANCY AT TIME OF SCREENING.
2. PREVIOUS HISTORY OF HYSTERECTOMY
3. PARTICIPATION IN ANOTHER CLINICAL TRIAL WITHIN LAST 30 DAYS.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Ami Fishman, Prof
Investigator Role:
Principal Investigator
Investigator Affiliation:
Meir medical Center, affiliated with Sackler School of Medicine, Tel-Aviv University
Authority:
Israel: The Israel National Institute for Health Policy Research and Health Services Research
Study ID:
ZT-CL-01A
NCT ID:
NCT01584414
Start Date:
October 2007
Completion Date:
April 2010
Related Keywords:
- Cervical Cancer
- Zetiq CellDetect ® stain
- distinct red/purple color to the cytoplasm of neoplastic
- distinguishes green/blue stained non-neoplastic cells and tissues
- Uterine Cervical Neoplasms